Quick answer: NAD+ sits at the center of how mitochondria convert food into ATP, carrying electrons into the electron transport chain and being regenerated so the upstream pathways can keep running. Mitochondrial output tends to decline with age through several overlapping changes, including accumulated damage, slower mitochondrial turnover and shifts in the NAD+ to NADH ratio. Restoring NAD+ in aged mice has improved mitochondrial and exercise measures across multiple studies. Human trials testing whether raising NAD+ changes energy, endurance or fatigue are still early, small and mixed, and that work is ongoing.
Energy, focus and recovery are the words people reach for when they describe what has changed since their thirties, and mitochondria are where all three eventually lead. Mitochondria depend on NAD+, and the mechanism is textbook biochemistry rather than marketing. What follows lays out what mitochondria do with NAD+, why output shifts with age, and what has been measured when people take NAD+ or its precursors.
What mitochondria do with NAD+
Mitochondria generate most of a cell's ATP, and NAD+ is what gets electrons to them. Fuel breakdown in glycolysis, fatty acid oxidation and the citric acid cycle strips electrons off substrate molecules and loads them onto NAD+, converting it to NADH. Without oxidized NAD+ available to accept those electrons, the upstream pathways slow regardless of how much fuel is present.
NADH then donates its electrons to complex I of the electron transport chain. Electrons moving through the chain pump protons across the inner mitochondrial membrane, and the gradient that builds drives ATP synthase to produce ATP. Regenerating NAD+ at that handoff keeps the whole sequence turning, which is why the ratio between NAD+ and NADH describes a cell's metabolic state better than either number alone.
Framing matters here, because NAD+ is not fuel. Calories carry the energy; NAD+ enables the transfer. A fuller account of the molecule's two roles, electron carrier and consumable substrate, is in what NAD+ is and what it actually does.
Why mitochondrial output changes with age
Mitochondrial function in older tissue differs from younger tissue in several measurable ways, and no single mechanism explains all of it. Reported changes include accumulated mitochondrial DNA mutations, reduced efficiency of the electron transport chain, lower rates of mitochondrial biogenesis and slower clearance of damaged mitochondria through mitophagy. Human muscle biopsy studies have found lower mitochondrial content and oxidative capacity in older adults.
Activity level accounts for part of that difference. Older adults are on average less active, and inactivity itself lowers mitochondrial content, which is why training status is now controlled for in the better designed studies.
Subjective fatigue adds another layer, since how tired a person feels correlates poorly with mitochondrial measurements. Sleep quality, thyroid function, iron status, mood, medication effects and training load all shape perceived energy, and none of them is an NAD+ question.
Where NAD+ enters the aging picture
Linking NAD+ to mitochondrial aging rests on two observations that are each well supported. First, NAD+ levels decline with age in animal tissue and, in a smaller set of studies, in human tissue. Second, sirtuins that depend on NAD+ regulate mitochondrial biogenesis and quality control, so lower NAD+ plausibly reduces that regulatory activity.
Consumption is the other half of the mechanism. PARP enzymes spend NAD+ while repairing DNA damage, and CD38 degrades it as well, with CD38 activity rising with age in mice. Rising consumption alongside unchanged or reduced synthesis produces the decline researchers describe.
Where the research currently stands
Mechanism and outcome are worth stating separately, once and plainly. The biochemistry above is well characterized and not in dispute, and the age related decline in both NAD+ and mitochondrial function is measured in animals and in human tissue.
Animal work is where the strongest intervention results sit. Aged mice given NAD+ precursors have shown improved mitochondrial function in muscle, greater exercise capacity, better vascular measures and improved insulin sensitivity across several well conducted studies.
Human trials are earlier. Oral nicotinamide riboside and nicotinamide mononucleotide reliably raise blood NAD+ markers in people, while trials measuring insulin sensitivity, muscle mitochondrial function, aerobic capacity and subjective fatigue have been small, short and mixed, with larger studies underway. Reading animal and human results in their proper places is the whole skill here, and how to read preclinical evidence without overreading it sets out a method.
Route makes a difference to what reaches circulation, though not to that evidence picture. Differences between infusion, injection and nasal delivery are worth understanding on their own terms, and how NAD+ IV, injection and nasal spray delivery differ covers what each route does and does not change.
Frequently Asked Questions
Does NAD+ give you more energy?
NAD+ is required for the reactions that produce ATP, so the mechanism connecting it to energy production is well established. Whether raising NAD+ increases felt energy in people is a separate question, and the human trials measuring fatigue and exercise capacity are small and mixed so far. What the research supports well is the mechanism; the lived effect is less settled.
Do mitochondria really decline with age?
Mitochondrial content and oxidative capacity are measurably lower in older muscle in human biopsy studies, and animal work shows the same pattern. Physical activity accounts for a substantial share of that difference, since inactivity reduces mitochondrial content independently of age. Teasing those two apart is one of the more interesting problems in the field.
Why did NAD+ work so well in mice but not clearly in people?
Mouse studies use short lived animals, tightly controlled conditions and amounts scaled to body size that do not map cleanly onto human use. Human trials also measure different endpoints, run for shorter relative fractions of a lifespan and enroll people with varied baseline health. Rodent results failing to reproduce in humans is common across aging research generally.
Would raising NAD+ help fatigue?
Fatigue has many causes, including sleep disruption, thyroid dysfunction, low iron, mood disorders, medication effects and overtraining, none of which is an NAD+ problem. Human trials measuring subjective fatigue after NAD+ precursor supplementation have not shown a consistent effect. Persistent fatigue is worth evaluating with a clinician who can look for a specific cause.
Is exercise a better way to affect mitochondria?
Exercise has the strongest human evidence for increasing mitochondrial content and oxidative capacity, with endurance training shown to do so repeatedly across age groups. Comparing that evidence base to the NAD+ literature, exercise is far better established today. Anyone interested in mitochondrial function has a well supported option available right now.
Do NAD+ blood levels tell you anything useful?
Blood NAD+ measurements reflect what is in circulation, and circulating levels do not reliably indicate what is happening inside muscle, brain or liver tissue. Trials have shown blood markers rising without matching changes in functional outcomes. Reading a blood number as evidence of benefit mixes a pharmacokinetic result with a clinical one.
The honest summary
NAD+ sits at the center of mitochondrial energy production, and the age related decline in both NAD+ and mitochondrial function is well enough established to take seriously. The open step is the last one, because showing that a molecule is necessary for a process is not the same as showing that adding more of it changes that process in a healthy adult. Animal results are strong, human results are early, and larger trials are the next thing to watch. Meanwhile, endurance training remains the intervention with the deepest human evidence for mitochondrial function, and any decision about a prescription therapy belongs with a licensed clinician.
References
Primary sources for the claims above. Where a study is preclinical, that is stated in the section it supports.
NAD(+) metabolism and its roles in cellular processes during ageing. Nature reviews. Molecular cell biology. 2021. PMID 33353981.
NAD+ and sirtuins in aging and disease. Trends in cell biology. 2014. PMID 24786309.
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023. PMID 36482258.
Compounded medications are not FDA-approved and are not the same as, nor a substitute for, FDA-approved products. Prescription products require an evaluation by a licensed provider who determines whether a prescription is appropriate. A prescription is not guaranteed. Individual results vary. Everhuman does not provide medical advice; clinical care is delivered by Arora Health.